FOR RELEASE ON
10 May 2023
IP Group - Director/PDMR share purchases
IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), which invests in breakthrough science and innovation companies with the potential to create a better future for all, has been notified that on 5 May 2023, Christopher Glasson, Finance Director and a PDMR, purchased a total of 49,690 Shares of 2p each as outlined in the table below.
Number of shares acquired
Price per share
Resulting beneficial interest
The notification below, made in accordance with the requirements of article 19 of the UK Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
Details of the person discharging managerial responsibilities / person closely associated
Reason for the notification
Finance Director (PDMR)
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
IP Group plc
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument
Ordinary Shares of 2p each in IP Group plc
Nature of the transaction
Purchase of shares
Price(s) and volume(s)
- Aggregated volume
55.12 pence per share
Date of the transaction
5 May 2023
Place of the transaction
London Stock Exchange, Main Market
For more information, please contact:
IP Group plc
Greg Smith, Chief Executive Officer
David Baynes, Chief Financial and Operating Officer
Liz Vaughan-Adams, Communications
+44 (0) 20 7444 0050
+44 (0) 20 7444 0062/+44 (0) 7967 312125
+44 (0) 7973 823119
+44 (0) 7516 729702
Notes for editors
About IP Group
IP Group accelerates the impact of science for a better future. As the most active UK based, early stage science investor, we develop and support some of the world's most exciting businesses in deeptech, life sciences and cleantech (led by Kiko Ventures). Through Parkwalk, the UK's largest growth EIS fund manager, we also back world-changing innovation emerging in leading universities and research institutions. Our specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, First Light Fusion, Hysata, and Oxbotica. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.
For more information, please visit our website at www.ipgroupplc.com.